We have previously shown that therapeutic vaccination with an HPV16 L2E7E6 fusion protein, TA-CIN, in the TC-1 tumor model upregulated PD-L1 on tumor cells and PD-1 on circulating CD8+ T cells (47). This evidence concerns the gene CD274 and neoplasm.